Stifel Financial’s Oramed Pharmaceuticals ORMP Stock Holding History

Stifel Financial’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-405,778	Closed	-$2.88M	–	2365
2014 Q4	$2.88M	Buy	405,778 +17,870	+5%	+$118K	0.02%	763
2014 Q3	$3.15M	Sell	387,908 -25,756	-6%	-$229K	0.03%	625
2014 Q2	$3.98M	Buy	413,664 +162,502	+65%	+$1.66M	0.04%	539
2014 Q1	$2.96M	Buy	+251,162	New	+$4.24M	0.03%	626

Other funds holding ORMP

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

GIM

Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FNBT

FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Stifel Financial's ORMP Position: Q1 2015 in Review

Stifel Financial sold out of Oramed Pharmaceuticals (ORMP) in Q1 2015, closing a stake of 405,778 shares — an estimated $2.88M sold.

Stifel Financial first reported a position in ORMP in Q1 2014 and held it in 4 quarters. The position peaked at $3.98M in Q2 2014. 17 funds tracked by Wall St. Rank hold ORMP as of Q1 2015.

Stifel Financial reported no remaining Oramed Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Stifel Financial sold 405,778 Oramed Pharmaceuticals shares in Q1 2015, an estimated $2.88M.
Stifel Financial first reported a position in Oramed Pharmaceuticals in Q1 2014 and held it in 4 quarters.
Stifel Financial's Oramed Pharmaceuticals position peaked at $3.98M in Q2 2014.
17 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2015.

Based on Stifel Financial's 13F filing for Q1 2015, filed 14 May 2015.